1.

Premature avoidable deaths by road traffic injuries in Belgium: trends and geographical disparities

2.

Premature avoidable deaths by road traffic injuries in Belgium: trends and geographical disparities

3.

Premature avoidable deaths by road traffic injuries in Belgium: trends and geographical disparities

1.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

2.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

3.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

4.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

5.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

6.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

7.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

8.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

9.

Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.

1.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

2.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

3.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

4.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

5.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

6.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

7.

Human herpes virus 8 infection in kidney transplant patients in Belgium.

1.

Long-term changes in the perception of Job Characteristics

1.

Employment status and mortality in the context of high and low regional unemployment levels in Belgium (2001-2011): A test of the social norm hypothesis across educational levels

2.

Employment status and mortality in the context of high and low regional unemployment levels in Belgium (2001-2011): A test of the social norm hypothesis across educational levels

3.

Employment status and mortality in the context of high and low regional unemployment levels in Belgium (2001-2011): A test of the social norm hypothesis across educational levels

1.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

2.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

3.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

4.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

5.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

6.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

7.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

8.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

9.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

1.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

2.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

3.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

4.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

5.

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

1.

Alexithymia is associated with glycaemic control of children with type 1 diabetes

2.

Alexithymia is associated with glycaemic control of children with type 1 diabetes

3.

Alexithymia is associated with glycaemic control of children with type 1 diabetes

1.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

2.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

3.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

4.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

5.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

6.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

7.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

8.

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.

1.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

2.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

3.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

4.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

5.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

6.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.

7.

SPICT as a predictive tool for risk of 1-year health degradation and death in older patients admitted to the emergency department: a bicentric cohort study in Belgium.